Skip to main content
Top
Published in: Gastric Cancer 2/2012

01-04-2012 | Original article

Clinicopathological features of stomach cancer with invasive micropapillary component

Authors: Takeo Fujita, Naoto Gotohda, Yuichiro Kato, Takahiro Kinoshita, Shinichiro Takahashi, Masaru Konishi, Hiroyuki Daiko, Mitsuyo Nishimura, Takeshi Kuwata, Atsushi Ochiai, Taira Kinoshita

Published in: Gastric Cancer | Issue 2/2012

Login to get access

Abstract

Background

Invasive micropapillary carcinoma has been recognized as a rare disease entity with aggressive tumor behavior. However, few reports have described invasive micropapillary carcinoma in the gastrointestinal tract, particularly its involvement in gastric cancer.

Methods

We retrospectively analyzed 930 patients diagnosed with gastric cancer who underwent gastrectomy, and we then histopathologically evaluated the existence of a regional invasive micropapillary component. Clinicopathological features were investigated in patients with an invasive micropapillary component and compared with such features in 100 patients with gastric adenocarcinoma, selected as stage-matched controls, who underwent gastrectomy during the same period.

Results

Of the 930 patients, 14 were histopathologically diagnosed with gastric cancer with a regional invasive micropapillary component. There were no significant differences in age, gender, tumor location, macroscopic type, or type of surgery between patients with an invasive micropapillary component and the pT-matched controls. Histopathologically, significant differences were observed in lymphatic infiltration, venous invasion, the percentage of cases with lymph node metastasis, and the median number of metastatic lymph nodes. The three-year disease-free and overall survival rates of patients with an invasive micropapillary component were 40.5 and 59.3%, respectively, compared with those for the stage-matched controls, which were 72.6 and 80.6%, respectively (p = 0.02 and 0.07).

Conclusions

Patients with gastric cancer with a regional invasive micropapillary component showed marked cancer infiltration in the lymphatic pathway and poor prognosis after gastrectomy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6:660–2.PubMed Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol. 1993;6:660–2.PubMed
2.
go back to reference Tavassoli FA, Devilee P. WHO classification of tumours, pathology and genetics, tumour of the breast and female genital organs. Lyon: IARC Press; 2003. p. 35–6. Tavassoli FA, Devilee P. WHO classification of tumours, pathology and genetics, tumour of the breast and female genital organs. Lyon: IARC Press; 2003. p. 35–6.
3.
go back to reference De La Cruz C, Moriya T, Endoh M, Watanabe M, Takeyama J, Yang M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54:90–6.CrossRef De La Cruz C, Moriya T, Endoh M, Watanabe M, Takeyama J, Yang M, et al. Invasive micropapillary carcinoma of the breast: clinicopathological and immunohistochemical study. Pathol Int. 2004;54:90–6.CrossRef
4.
go back to reference Amin MB, Ro JY, El-Sharkawy T, Lee KM, Troncoso P, Silva EG, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224–32.PubMedCrossRef Amin MB, Ro JY, El-Sharkawy T, Lee KM, Troncoso P, Silva EG, et al. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol. 1994;18:1224–32.PubMedCrossRef
5.
go back to reference Oh YL, Kim KR. Micropapillary variant of transitional cell carcinoma of the ureter. Pathol Int. 2000;50:52–6.PubMedCrossRef Oh YL, Kim KR. Micropapillary variant of transitional cell carcinoma of the ureter. Pathol Int. 2000;50:52–6.PubMedCrossRef
6.
go back to reference Amin MB, Tamboli P, Merchant SH, Ordöňez NG, Ro J, Ayala AG, et al. Micropapillary component in lung adenocarcinoma: distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358–64.PubMedCrossRef Amin MB, Tamboli P, Merchant SH, Ordöňez NG, Ro J, Ayala AG, et al. Micropapillary component in lung adenocarcinoma: distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358–64.PubMedCrossRef
7.
go back to reference Michal M, Skalova A, Mukensnabl P. Micropapillary carcinoma of the parotid gland arising in mucinous cystadenoma. Virchows Arch. 2000;437:465–8.PubMedCrossRef Michal M, Skalova A, Mukensnabl P. Micropapillary carcinoma of the parotid gland arising in mucinous cystadenoma. Virchows Arch. 2000;437:465–8.PubMedCrossRef
8.
go back to reference Shimoda M, Okada Y, Hayashi Y, Hatano S, Kawakubo H, Omori T, et al. Primary invasive micropapillary carcinoma of the stomach. Pathol Int. 2008;58:513–7.PubMedCrossRef Shimoda M, Okada Y, Hayashi Y, Hatano S, Kawakubo H, Omori T, et al. Primary invasive micropapillary carcinoma of the stomach. Pathol Int. 2008;58:513–7.PubMedCrossRef
9.
go back to reference Sakamoto K, Watanabe M, De La Cruz C, Honda H, Ise H, Mitsui K, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology. 2005;47:79–84. Sakamoto K, Watanabe M, De La Cruz C, Honda H, Ise H, Mitsui K, et al. Primary invasive micropapillary carcinoma of the colon. Histopathology. 2005;47:79–84.
10.
go back to reference Trabelsi A, Ali AB, Yacoub-Abid LB, Stita W, Mokni M, Korbi S. Primary invasive micropapillary carcinoma of the colon: case report and review of the literature. Pathologica. 2008;100:428–30.PubMed Trabelsi A, Ali AB, Yacoub-Abid LB, Stita W, Mokni M, Korbi S. Primary invasive micropapillary carcinoma of the colon: case report and review of the literature. Pathologica. 2008;100:428–30.PubMed
11.
go back to reference Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998;1:10–24. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998;1:10–24.
12.
go back to reference Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg. 1992;79:245–7.PubMedCrossRef Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg. 1992;79:245–7.PubMedCrossRef
13.
go back to reference Peterse JL. Breast carcinoma with an unexpected inside out growth pattern. Rotation of polarization associated with angioinvasion. Pathol Res Pract. 1993;189:780. (abstract). Peterse JL. Breast carcinoma with an unexpected inside out growth pattern. Rotation of polarization associated with angioinvasion. Pathol Res Pract. 1993;189:780. (abstract).
14.
go back to reference Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathological study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Surg Pathol. 2004;121:857–66. Pettinato G, Manivel CJ, Panico L, Sparano L, Petrella G. Invasive micropapillary carcinoma of the breast: clinicopathological study of 62 cases of a poorly recognized variant with highly aggressive behavior. Am J Surg Pathol. 2004;121:857–66.
15.
go back to reference Chen L. Breast carcinoma with micropapillary features: clinicopathological study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16:155–63.PubMedCrossRef Chen L. Breast carcinoma with micropapillary features: clinicopathological study and long-term follow-up of 100 cases. Int J Surg Pathol. 2008;16:155–63.PubMedCrossRef
16.
go back to reference Kuroda H, Sakamoto G, Ohnishi K, Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer. 2004;11:169–74.PubMedCrossRef Kuroda H, Sakamoto G, Ohnishi K, Itoyama S. Clinical and pathologic features of invasive micropapillary carcinoma. Breast Cancer. 2004;11:169–74.PubMedCrossRef
17.
go back to reference Roger L, Jullien L, Gire V, Roux P. Gain of oncogenic function of p53 mutant regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010;123:1295–305.PubMedCrossRef Roger L, Jullien L, Gire V, Roux P. Gain of oncogenic function of p53 mutant regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010;123:1295–305.PubMedCrossRef
18.
go back to reference Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol. 1995;8:177–90.PubMed Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, et al. Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol. 1995;8:177–90.PubMed
19.
go back to reference Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 2003;201:97–106.PubMedCrossRef Chen HC, Chu RY, Hsu PN, Hsu PI, Lu JY, Lai KH, et al. Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 2003;201:97–106.PubMedCrossRef
20.
go back to reference Middleton LP, Tressera F, Sobol ME, Bryant BR, Alburquerque A, Grases P, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499–504.PubMed Middleton LP, Tressera F, Sobol ME, Bryant BR, Alburquerque A, Grases P, et al. Infiltrating micropapillary carcinoma of the breast. Mod Pathol. 1999;12:499–504.PubMed
21.
go back to reference Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32:583–9.PubMedCrossRef Walsh MM, Bleiweiss IJ. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol. 2001;32:583–9.PubMedCrossRef
22.
go back to reference Luna-More S, Casquero S, Perez-Mellado A, Rius F, Weill B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract. 2000;196:35–9.PubMedCrossRef Luna-More S, Casquero S, Perez-Mellado A, Rius F, Weill B, Gornemann I. Importance of estrogen receptors for the behavior of invasive micropapillary carcinoma of the breast. Review of 68 cases with follow-up of 54. Pathol Res Pract. 2000;196:35–9.PubMedCrossRef
23.
go back to reference Varga Z, Zhao J, Ohlschlegel C, Odermatt B, Heitz PU. Preferential HER2/neu overexpression and/or amplification in aggressive histopathological subtypes of invasive breast cancer. Histopathology. 2004;44:332–8.PubMedCrossRef Varga Z, Zhao J, Ohlschlegel C, Odermatt B, Heitz PU. Preferential HER2/neu overexpression and/or amplification in aggressive histopathological subtypes of invasive breast cancer. Histopathology. 2004;44:332–8.PubMedCrossRef
24.
Metadata
Title
Clinicopathological features of stomach cancer with invasive micropapillary component
Authors
Takeo Fujita
Naoto Gotohda
Yuichiro Kato
Takahiro Kinoshita
Shinichiro Takahashi
Masaru Konishi
Hiroyuki Daiko
Mitsuyo Nishimura
Takeshi Kuwata
Atsushi Ochiai
Taira Kinoshita
Publication date
01-04-2012
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 2/2012
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-011-0094-5

Other articles of this Issue 2/2012

Gastric Cancer 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.